ForGrowth III PA B.V. and Affiliates Beneficial Ownership in Vor Biopharma Inc.

ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., and Forbion Growth III Management B.V. (collectively referred to as the Reporting Persons) have filed a Schedule 13G indicating beneficial ownership of 9.99% of the outstanding Common Stock of Vor Biopharma Inc. This ownership is attributed to the acquisition of pre-funded warrants to purchase up to 7,000,000 shares of Common Stock at an exercise price of $0.002 per share. The warrants became exercisable on September 18, 2025, subject to a beneficial ownership limitation of 9.99% of the outstanding shares immediately after exercise. The Reporting Persons disclaim membership in a group for the purposes of Rule 13d-5 under the Securities Exchange Act of 1934.